Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Colorectal Cancer Screening Market Size, Value And Growth Trajectory Through 2030
The colorectal cancer screening market has experienced substantial growth in recent years. It is projected to expand from $16.56 billion in 2025 to $17.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. This historic growth can be attributed to several factors, including the increasing prevalence of colorectal cancer, the broadening of national screening guidelines, heightened awareness regarding the benefits of early diagnosis, the wider adoption of fecal-based screening methods, and enhanced access to diagnostic services.
The colorectal cancer screening market is anticipated to experience substantial expansion in the coming years. It is forecast to grow to $22.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. This projected growth can be linked to factors such as increased screening participation among younger demographics, the growing integration of artificial intelligence in endoscopy procedures, the expansion of telehealth-supported screening initiatives, a heightened focus on personalized cancer risk assessment, and rising investments in preventive healthcare infrastructure. Notable trends expected during this forecast period include the increasing adoption of non-invasive screening tests, the greater utilization of AI-assisted colonoscopy systems, a rising demand for home-based stool testing kits, the widespread implementation of population-wide screening programs, and an intensified commitment to early detection and preventive care.
Get A Free Sample Report With In-Depth Market Insights:
Colorectal Cancer Screening Market Growth Drivers: What’s Behind The Acceleration?
The expansion of the colorectal cancer screening market is anticipated to be driven by the rising elderly demographic. An aging population describes a demographic shift characterized by a growing share of older individuals (generally those aged 65 and above) compared to the working-age segment, frequently stemming from extended life spans and reduced birth rates. This demographic’s growth is a result of increased life expectancies and decreased birth rates, contributing to a larger percentage of seniors globally. For the expanding elderly population, colorectal cancer screening is vital, facilitating early diagnosis and preventative actions to mitigate the heightened cancer risk among older adults and improve their general health results. As an illustration, data released in January 2024 by the Population Reference Bureau (PRB), a US-based nonprofit research entity, projects that the population of Americans aged 65 and above will climb from 58 million in 2022 to 82 million by 2050, representing a 47% surge, with their share of the total population projected to increase from 17% to 23%. Consequently, the expanding older demographic is propelling the colorectal cancer screening market.
Colorectal Cancer Screening Market Segments: Where Is Growth Concentrated?
The colorectal cancer screening market covered in this report is segmented –
1) By Type: Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
2) By Age Group: Below 50 Years, 50-64 Years, Above 65 Years
3) By End User: Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users
Subsegments:
1) By Stool-Based: Stool-Based Tests
2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT, Low-Sensitivity FIT
3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT, Immunochemical FOBT
4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test, Single-Target Stool DNA Test
5) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy
6) By Other Types: Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy
Colorectal Cancer Screening Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the colorectal cancer screening market are concentrating on developing advanced solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests. These innovations aim to provide an accessible and effective method for the early detection of colorectal cancer, thereby improving patient outcomes and fostering broader screening participation. These non-invasive multi-target stool RNA colorectal cancer screening tests operate by analyzing RNA markers from a stool sample to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early identification. For example, in May 2024, Geneoscopy Inc., a US-based life sciences company, announced the U.S. Food and Drug Administration (FDA) approval of ColoSense. This test employs RNA biomarkers for a non-invasive, stool-based screening, demonstrating 93% sensitivity for detecting colorectal cancer and 45% sensitivity for advanced adenomas. The significance of this lies in its high accuracy, especially in younger populations, and its potential to increase screening rates by providing a less invasive alternative to traditional methods.
Colorectal Cancer Screening Market Key Participants And Competitive Landscape
Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA
View The Full Colorectal Cancer Screening Market Report:
Colorectal Cancer Screening Market Top Region By Revenue And Market Share
North America was the largest region in the colorectal cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
